AU
UK
CA
NZ
IND
US
Key Highlights
Key Highlights
Co-Diagnostics (Nasdaq: CODX) surged nearly 89% after advancing development of Bundibugyo Ebola PCR assays with partner CoSara. Investors are reacting to rising outbreak concerns in Africa and growingDemandexpectations for decentralized infectious disease diagnostics.
Key Highlights
Key Highlights
Enovis (NYSE: ENOV) traded around $24.59 on May 21, 2026, ending the session roughly 7.07% lower. DailyVolumeof 1.45M compared to a relative-volume reading of 1.07, andMarket Capitalisationstood at 1.42B. Trailing twelve-month diluted EPS was reported at -19.86, with EPS growth of -37.16%.
Key Highlights
Key Highlights
Please wait processing your request...